bromodeoxyuridine has been researched along with decitabine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haaf, T; Ott, G; Schmid, M | 1 |
| Feichtinger, W; Schmid, M | 1 |
| Bernardino-Sgherri, J; Dutrillaux, B; Flagiello, D | 1 |
| Flaswinkel, H; Hoeflich, A; Shi, W; Stojkovic, M; Wolf, E; Zakhartchenko, V | 1 |
| Engelbrecher, A; Häuser, R; Titz, B; Uetz, P | 1 |
| Chan, AK; Lau, KM; Li, KK; Mao, Y; Ng, HK; Pang, JC; Poon, WS; Shi, Z; Wang, Y; Yang, L; Zhou, L | 1 |
| Moolmuang, B; Ruchirawat, M; Singhirunnusorn, P | 1 |
7 other study(ies) available for bromodeoxyuridine and decitabine
| Article | Year |
|---|---|
Differential inhibition of sister chromatid condensation induced by 5-azadeoxycytidine in human chromosomes.
Topics: Azacitidine; Bromodeoxyuridine; Chromatids; Decitabine; Depression, Chemical; Humans; Male; Metaphase; Sister Chromatid Exchange; Staining and Labeling | 1986 |
Increased frequencies of sister chromatid exchanges at common fragile sites (1)(q42) and (19)(q13).
Topics: Azacitidine; Bromodeoxyuridine; Cells, Cultured; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Decitabine; Humans; Karyotyping; Sister Chromatid Exchange | 1989 |
Complex relationships between 5-aza-dC induced DNA demethylation and chromosome compaction at mitosis.
Topics: Azacitidine; Bromodeoxyuridine; Cell Cycle; Chromosomes; Decitabine; DNA; DNA Methylation; Immunohistochemistry; Mitosis; Staining and Labeling | 2002 |
Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos.
Topics: Animals; Apoptosis; Azacitidine; Bromodeoxyuridine; Butyrates; Cattle; Cell Differentiation; Cell Division; Cell Line; Cellular Senescence; Decitabine; DNA Methylation; Embryonic and Fetal Development; Enzyme Inhibitors; Epithelial Cells; Female; Histone Deacetylase Inhibitors; Hydroxamic Acids; In Vitro Techniques; Mammary Glands, Animal; Nuclear Transfer Techniques; Oocytes; Phenotype; Ploidies | 2003 |
The Escherichia coli protein YjjG is a house-cleaning nucleotidase in vivo.
Topics: Azacitidine; Bromodeoxyuridine; Decitabine; Deoxyuridine; DNA Damage; Escherichia coli; Escherichia coli Proteins; Fluorouracil; Models, Biological; Molecular Structure; Mutation; N-Glycosyl Hydrolases; Nucleotidases; Orotic Acid; Substrate Specificity; Thymidine Monophosphate; Uridine | 2007 |
MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L.
Topics: Adult; Aged; Azacitidine; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cellular Apoptosis Susceptibility Protein; Child; Cohort Studies; Collagen; Decitabine; Down-Regulation; Drug Combinations; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Kaplan-Meier Estimate; Laminin; Male; MicroRNAs; Middle Aged; Oligodendroglioma; Proteoglycans | 2013 |
Effects of 5-Aza-2'-Deoxycytidine, Bromodeoxyuridine, Interferons and Hydrogen Peroxide on Cellular Senescence in Cholangiocarcinoma Cells.
Topics: Azacitidine; Bile Duct Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cellular Senescence; Cholangiocarcinoma; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA Damage; Humans; Hydrogen Peroxide; Interferons; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |